Thalidomide Modulates Oxidative Stress and Tubular Pathology in Renal Ischemia-Reperfusion in a Timing-Dependent Manner
Recent Trends in Pharmacology · 2026
DOI: 10.62425/rtpharma.1780199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Recent Trends in Pharmacology, 2026. Verfasst von Onural Özhan und 7 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Research Fund of the Inonu University.
Abstract (Originalsprache)
Background
Renal ischemia–reperfusion (IR) drives acute kidney injury through oxidative stress and inflammation. Thalidomide (TD), an immunomodulatory agent, may attenuate IR-related biochemical and structural damage.
Methods
Thirty-two female Wistar albino rats were randomized to four groups (n=8): Sham, IR, TD+IR (20 mg/kg i.p. 30 min before ischemia), and IR+TD (20 mg/kg i.p. immediately after 60-min ischemia). All animals underwent right nephrectomy, left renal ischemia (60 min), and 24-h reperfusion. Outcomes included serum blood urea nitrogen (BUN)/creatinine (CR)/albumin; renal malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), catalase (CAT); and histopathology (tubular dilatation, epithelial shedding, intertubular congestion).
Results
IR increased BUN/CR versus Sham, while albumin was unchanged. TD+IR modestly lowered BUN/CR compared with IR, whereas IR+TD did not improve these indices at 24 h. MDA rose with IR and was reduced by TD+IR (vs IR), but not by IR+TD; CAT fell with IR and was highest in IR+TD, while GSH and SOD showed no significant group differences. Histologically, IR produced tubular epithelial shedding, dilatation, and intertubular congestion. TD+IR improved all parameters except epithelial shedding (vs IR), and IR+TD improved all except tubular dilatation; medullary congestion decreased in both TD groups, more prominently with IR+TD.
Conclusion
TD confers schedule-dependent renoprotection in renal IR. Pre-ischemic dosing more consistently preserves function and limits lipid peroxidation, whereas post-ischemic dosing better enhances CAT activity and alleviates medullary congestion. These data support TD as a context-dependent adjunct for peri-ischemic kidney protection.
Förderung
- Research Fund of the Inonu University
Zitieren
APA
Özhan, O., Mete, U. C., Yıldız, A., Durhan, M., Vardı, N., Çiğremiş, Y., Acet, A., & Parlakpınar, H. (2026). Thalidomide Modulates Oxidative Stress and Tubular Pathology in Renal Ischemia-Reperfusion in a Timing-Dependent Manner. Recent Trends in Pharmacology. https://doi.org/10.62425/rtpharma.1780199
Vancouver
Özhan O, Mete UC, Yıldız A, Durhan M, Vardı N, Çiğremiş Y, et al. Thalidomide Modulates Oxidative Stress and Tubular Pathology in Renal Ischemia-Reperfusion in a Timing-Dependent Manner. Recent Trends in Pharmacology. 2026. doi:10.62425/rtpharma.1780199
BibTeX
@article{zhan2026,
author = {Özhan, Onural and Mete, Ugur Cem and Yıldız, Azibe and Durhan, Merve and Vardı, Nigar and Çiğremiş, Yılmaz and Acet, Ahmet and Parlakpınar, Hakan},
title = {Thalidomide Modulates Oxidative Stress and Tubular Pathology in Renal Ischemia-Reperfusion in a Timing-Dependent Manner},
journal = {Recent Trends in Pharmacology},
year = {2026},
doi = {10.62425/rtpharma.1780199}
}
EUVIMED